BIG PHARMA PARTNERING WITH TELEHEALTH — HELPING PATIENTS or ENCOURAGING BAD PRESCRIBING ?
Current rules from the FDA apply to drug companies’ ads, requiring them to show risks. But telehealth companies aren’t held to the same standards — even when they promote the same drugs. That could mislead patients.
Are doctors favoring drugs from partner companies?
Are patients being properly evaluated?
What exactly are the companies paying each other for?
Is the Anti-Kickback Statute (AKS) being violated?
